Items Tagged with 'pharmaceuticals'

ARTICLES

Doctors, hospitals worry about shortage of medication

November 15, 2013
LANSING — Michigan is experiencing the nationwide problem of insufficient pharmaceutical drugs. Read More

Perrigo prescribes marketing campaign for store-brand meds

May 16, 2013
Allegan-based Perrigo has begun what it claims is the first broad marketing and communications campaign to raise consumer awareness of, and confidence in, generic over-the-counter medications sold by major retailers under their own store brands. Read More

Perrigo acquires Rosemont Pharmaceuticals for $283M to expand in U.K.

February 12, 2013
Perrigo (Nasdaq: PRGO) has signed a merger agreement and completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals Ltd. for approximately £180 million or $283 million in cash. Read More

Perrigo acquires Velcera for $160M to expand in pet-health market

February 5, 2013
Perrigo has signed a definitive agreement to acquire Velcera Inc. — an OTC pet health-products company in Yardley, Pa. — for $160 million in cash, with the acquisition expected to close this year. Read More

Perrigo acquires remaining stake in Cobrek Pharmaceuticals for $45M

January 7, 2013
Allegan pharmaceutical manufacturer Perrigo (Nasdaq: PRGO) has announced it has signed a definitive merger agreement and completed full acquisition of Cobrek Pharmaceuticals Inc., a privately-held, Chicago based drug development company, for approximately $45 million on a cash free and debt-free basis. Read More

Perrigo partner gets FDA approval for generic scalp-psoriasis treatment

December 3, 2012
Perrigo has announced that its partner, Cobrek Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration for its generic equivalent to Luxiq, a foam treatment for scalp psoriasis, with Perrigo now set to begin commercial shipments of it in mid January. Read More

Perrigo's first quarter of FY13 shows record net income

November 8, 2012
Perrigo (Nasdaq:PRGO), the Allegan-based global company that is among the world’s largest manufacturers of over-the-counter pharmaceuticals, has just reported adjusted net income in the first quarter of a record $119 million or $1.27 per diluted share. Management has also raised Perrigo’s adjusted EPS guidance for the new fiscal year to reflect the acquisition of Sergeant’s Pet Care Products. Read More